Lung Cancer

Top Story

FDA grants priority review to Tecentriq for first-line treatment of advanced non-small cell lung cancer

February 19, 2020
FDA News

FDA grants priority review to lurbinectedin for relapsed small cell lung cancer

February 17, 2020
The FDA granted priority review to lurbinectedin for the treatment of small cell lung cancer that relapsed after platinum-based therapy, according to a press release…
In the Journals

Study evaluates malignancy prediction models for pulmonary nodules

February 14, 2020
In a study of models for predicting malignancy in pulmonary nodules, researchers found that those developed using data from the Pan-Canadian Early Detection of Lung…
FDA News

FDA grants capmatinib priority review for non-small cell lung cancer subset

February 11, 2020
The FDA granted priority review to capmatinib for the treatment of patients with advanced non-small cell lung cancer who harbor MET exon 14 skipping mutations. …
More Headlines »
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

More »
Video
Meeting News

VIDEO: Studies in lung cancer, sarcoma highlight Eli Lilly presentations at ASCO

June 20, 2019
More »
CME

Ace the Case: A 67-Year-Old Man Presents With Pain and Swelling of His Hands and Knees

There is no commercial support for this activity.

More »